Date: May 17, 2011
To: All Workers' Compensation Medical Providers
This bulletin clarifies recommendations contained in the Neck Injury Medical Treatment Guidelines regarding the use of Clopidogrel and other anti-platelet/anti-coagulant therapies prior to diagnostic and/or therapeutic injections.
Section D.3.a of the Neck Injury Medical Treatment Guideline states:
"Relative contraindications to diagnostic injections may include: allergy to contrast, poorly controlled Diabetes Mellitus and hypertension. Drugs affecting coagulation may require restriction from use. The following are suggested time period restrictions:
The stated time frames for withholding anti-coagulant or anti-platelet medications prior to injections are "suggested time period restrictions." Patients who undergo any procedure where anti-coagulant or anti-platelet therapies may require restriction should have these medications appropriately evaluated and managed by the treating physician or identified specialist.
Please contact the Board's Bureau of Health Management at (800) 781-2362 if you have any questions.
Dr. Jaime Szeinuk
Robert E. Beloten